Latest filing published 20 Nov 2017 for Pacira BioSciences, Inc., €30k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -42.9%Entry US$63.84 · Close at T+365 US$36.45
- -41.3%Entry US$67.32 · Close at T+365 US$39.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
James B. Jones: trading record in brief
James B. Jones is a declared insider of Pacira BioSciences, Inc., with filings sourced from SEC (Form 4). We count 6 filings; the first trade dates from 12 January 2016 and the latest from 20 November 2017.
The open-market side counts 2 purchases for €90k alongside 2 sales for €59k. Purchases outweigh sales by €30k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 share grants. In 2017 alone, the filings show no purchases and 2 sales.
The latest filing, published on 20 November 2017, reports an open-market sale of €30k in Pacira BioSciences, Inc. The last insider purchase was made public on 29 January 2016, 3,937 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to James B. Jones
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 850 shares@ US$41.1120.0% of flowCommon StockSEC:0001209191-17-061873:0
- 7,500 shares0Common StockSEC:0001209191-17-040678:0
- 767 shares@ US$43.3219.8% of flowCommon StockSEC:0001209191-17-038417:0
- 8,750 shares0Common StockSEC:0001209191-16-128629:0
- 500 shares@ US$62.5032.1% of flowCommon StockSEC:0001209191-16-094276:0Canonical exit: 26 Apr 2016 (T+90)
- 1,000 shares@ US$66.0067.9% of flowCommon StockSEC:0001209191-16-091535:0Canonical exit: 11 Apr 2016 (T+90)
6 of 6 declarations
